Advertisement
IGCS is proud to be featured in the second installment of the Union for International Cancer Control Rewriting Cancer Series, produced for them by BBC StoryWorks Commercial Productions. The series showcases organizations around the world that are transforming cancer prevention, diagnosis, treatment, and care through innovation and collaboration. ..
We are extremely proud to announce that the latest Impact Factor for the International Journal of Gynecological Cancer has risen to 5.4. Congratulations to Pedro and the entire IJGC team!..
The International Gynecologic Cancer Society (IGCS) and the Society of Abdominal Radiology (SAR) are proud to announce a new collaborative partnership formalized through a Memorandum of Understanding (MOU) aimed at advancing education, research, and interdisciplinary collaboration in the care of patients with gynecologic cancers...
The IGCS is proud to partner with The ICCP in the launch of a new global map of national cervical cancer elimination strategies and an expanded resource hub designed to support countries working toward the WHO 90:70:90 targets by 2030, as a meaningful step on the path to elimination of cervical cancer globally...
IGCS was approached by the Union for International Cancer Control (UICC) to be featured in their Rewriting Cancer film series, produced for them by BBC StoryWorks Commercial Productions. Being selected for the series is a tremendous recognition of our flagship Gynecologic Oncology Global Fellowship Program — and of the extraordinary work happening across all 23 fellowship sites worldwide...
We are pleased to announce that the Brazilian Gynecologic Oncology Group – EVA Group– has officially joined the International Gynecologic Cancer Society’s Strategic Alliance Partner Program. Founded in 2013, EVA is a respected, mission-driven, nonprofit association dedicated to advancing gynecologic cancer care across Brazil through education, research, prevention, awareness and comprehensive patient support...
Its membership renewal season and the perfect time to join IGCS if you are not currently a member. All dues payments are applied to the 2026 membership term. IGCS provides year-round education, mentorship and training opportunities, and most recently, advocacy and outreach programming in support of our mission...
We are pleased to share important news for our global community. A major new international study, “Experiences of Women with Ovarian Cancer in 22 Low- and Middle- Income Countries (Every Woman Study™ LMIC): a Cross-sectional Study,” was published today in the The Lancet Obstetrics, Gynaecology, & Women’s Health...
As we move through the holiday season and transition into a new year, IGCS CEO Mary Eiken reflects on the guiding principles that shape her leadership. Listen to our special year-end podcast episode to learn what grounds her: leading with gratitude, focusing on impact, and advancing equity in global cancer care...
Uterine cancer is the second most common gynecological cancer globally, but often it is missing from national cancer plans and global health priorities. Without political attention, there is no accountability, no funding, and no progress. The position paper on uterine cancer “Spotlight on uterine cancer: Shaping access to equitable and high-quality care”, which IGCS co-authored with like-minded organizations from around the world, including AstraZeneca, is a call to governments and policymak..
IGCAN Directory
login/create account
Donate